byiShook Opinion
Feb 19, 2025 - 12:10
Harmony Sciences shares plunged Wednesday after the FDA rejected its bread-and-butter drug as a treatment for a daytime sleepiness condition. The post Harmony Biosciences Crashes On Surprise Rejection For Bread-And-Butter Drug appeared first on Investor's Business Daily.
Harmony Sciences shares plunged Wednesday after the FDA rejected its bread-and-butter drug as a treatment for a daytime sleepiness condition.
The post Harmony Biosciences Crashes On Surprise Rejection For Bread-And-Butter Drug appeared first on Investor's Business Daily.